Sakar Healthcare (India) Today

SAKAR Stock   291.05  0.40  0.14%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
Sakar Healthcare is selling at 291.05 as of the 29th of November 2024; that is 0.14 percent decrease since the beginning of the trading day. The stock's open price was 291.45. Sakar Healthcare has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sakar Healthcare Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of December 2022 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Sakar Healthcare is entity of India. It is traded as Stock on NSE exchange. The company has 21.75 M outstanding shares. More on Sakar Healthcare Limited

Moving together with Sakar Stock

  0.68ICICIGI ICICI Lombard GeneralPairCorr

Moving against Sakar Stock

  0.65FORTIS Fortis HealthcarePairCorr

Sakar Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sakar Healthcare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sakar Healthcare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors)
Sakar Healthcare's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Sakar Healthcare's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Sakar Healthcare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sakar Healthcare's financial leverage. It provides some insight into what part of Sakar Healthcare's total assets is financed by creditors.
Liquidity
Sakar Healthcare cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Sakar Healthcare Limited has accumulated 793.52 M in total debt. Debt can assist Sakar Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Sakar Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sakar Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sakar to invest in growth at high rates of return. When we think about Sakar Healthcare's use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

(996.69 Million)
Sakar Healthcare Limited (SAKAR) is traded on National Stock Exchange of India in India and employs 325 people. Sakar Healthcare is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sakar Healthcare's market, we take the total number of its shares issued and multiply it by Sakar Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sakar Healthcare operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 21.75 M outstanding shares. Sakar Healthcare Limited has accumulated about 933 K in cash with 244.67 M of positive cash flow from operations.
Check Sakar Healthcare Probability Of Bankruptcy

Sakar Healthcare Risk Profiles

Although Sakar Healthcare's alpha and beta are two of the key measurements used to evaluate Sakar Healthcare's performance over the market, the standard measures of volatility play an important role as well.

Sakar Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sakar Healthcare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Sakar Healthcare Corporate Management

Elected by the shareholders, the Sakar Healthcare's board of directors comprises two types of representatives: Sakar Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sakar. The board's role is to monitor Sakar Healthcare's management team and ensure that shareholders' interests are well served. Sakar Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sakar Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dharmesh ThakerChief OfficerProfile
Ritaben ShahWholeTime DirectorProfile
Bharat SoniCompany OfficerProfile
Sanjay ShahChairman MDProfile
Aarsh ShahJoint DirectorProfile

Other Information on Investing in Sakar Stock

Sakar Healthcare financial ratios help investors to determine whether Sakar Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sakar with respect to the benefits of owning Sakar Healthcare security.